Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $574.58 | 43 | 82.8% |
| Education | $118.99 | 3 | 17.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $255.57 | 13 | $0 (2023) |
| Dermavant Sciences, Inc. | $147.40 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $91.99 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $44.90 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $41.83 | 1 | $0 (2022) |
| ABBVIE INC. | $36.54 | 2 | $0 (2022) |
| Arcutis Biotherapeutics, Inc. | $34.94 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $27.00 | 2 | $0 (2017) |
| GENZYME CORPORATION | $13.40 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.64 | 27 | Dermavant Sciences, Inc. ($147.40) |
| 2023 | $232.50 | 12 | UCB, Inc. ($232.50) |
| 2022 | $101.44 | 4 | E.R. Squibb & Sons, L.L.C. ($41.83) |
| 2018 | $91.99 | 1 | Janssen Biotech, Inc. ($91.99) |
| 2017 | $27.00 | 2 | Galderma Laboratories, L.P. ($27.00) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: DERMATOLOGY | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: DERMATOLOGY | ||||||
| 10/01/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: DERMATOLOGY | ||||||
| 09/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.14 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: DERMATOLOGY | ||||||
| 08/06/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: DERMATOLOGY | ||||||
| 07/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: DERMATOLOGY | ||||||
| 06/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Dermatology | ||||||
| 06/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: DERMATOLOGY | ||||||
| 06/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.79 | General |
| Category: DERMATOLOGY | ||||||
| 05/28/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.68 | General |
| Category: DERMATOLOGY | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: DERMATOLOGY | ||||||
| 05/01/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: DERMATOLOGY | ||||||
| 04/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: DERMATOLOGY | ||||||
| 03/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: DERMATOLOGY | ||||||
| 03/11/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: DERMATOLOGY | ||||||
| 02/14/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: DERMATOLOGY | ||||||
| 02/07/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: Dermatology | ||||||
| 02/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,729 | 2,626 | $700,580 | $104,244 |
| 2022 | 17 | 1,854 | 2,800 | $749,851 | $113,771 |
| 2021 | 20 | 1,903 | 2,930 | $757,644 | $122,180 |
| 2020 | 18 | 1,821 | 2,906 | $672,317 | $98,708 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 536 | 658 | $156,009 | $38,919 | 24.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 344 | 375 | $169,623 | $24,582 | 14.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 152 | 152 | $54,568 | $11,862 | 21.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 287 | 320 | $119,680 | $10,019 | 8.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 211 | 903 | $70,434 | $4,549 | 6.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 21 | 22 | $20,218 | $2,613 | 12.9% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 31 | 35 | $18,021 | $2,403 | 13.3% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 17 | $17,935 | $2,290 | 12.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 34 | 38 | $26,638 | $1,901 | 7.1% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 19 | 22 | $14,058 | $1,815 | 12.9% |
| 11200 | Removal of skin tag, 1-15 skin tags | Office | 2023 | 47 | 47 | $20,069 | $1,534 | 7.6% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 17 | $10,047 | $1,066 | 10.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 20 | $3,280 | $690.72 | 21.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 580 | 719 | $163,213 | $42,552 | 26.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 323 | 355 | $152,650 | $22,345 | 14.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 160 | 160 | $55,840 | $11,942 | 21.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 301 | 361 | $131,765 | $11,675 | 8.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 213 | 905 | $68,780 | $4,439 | 6.5% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 28 | 30 | $30,870 | $4,286 | 13.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 46 | 50 | $34,200 | $2,776 | 8.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 51 | 57 | $9,120 | $1,996 | 21.9% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 15 | 16 | $15,136 | $1,950 | 12.9% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2022 | 23 | 24 | $13,536 | $1,570 | 11.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 14 | 15 | $13,455 | $1,522 | 11.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 11 | 13 | $16,068 | $1,435 | 8.9% |
About Dr. James Schuster, MD
Dr. James Schuster, MD is a Dermatology healthcare provider based in Fond Du Lac, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1780660308.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Schuster, MD has received a total of $693.57 in payments from pharmaceutical and medical device companies, with $240.64 received in 2024. These payments were reported across 46 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($574.58).
As a Medicare-enrolled provider, Schuster has provided services to 7,307 Medicare beneficiaries, totaling 11,262 services with total Medicare billing of $438,903. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Fond Du Lac, WI
- Active Since 12/15/2005
- Last Updated 12/16/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1780660308
Products in Payments
- Briviact (Drug) $233.03
- VTAMA (Drug) $147.40
- Tremfya (Drug) $91.99
- DUPIXENT (Biological) $58.30
- SKYRIZI (Biological) $36.54
- Zoryve (Drug) $34.94
- EPIDUO FORTE (Drug) $27.00
- Cimzia (Drug) $22.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.